Ads
related to: acute myeloid leukemia news- Treatment Option
Visit The Physician Website To
Learn More About This Treatment.
- Mechanism Of Action
Learn How To Treat Patients
With Ph+ CML-CP Today.
- Efficacy Information
Physicians, See How This Treatment
May Help Your Patients Today.
- Safety Profile
Physicians, See Important Safety
Information About This Treatment.
- View Patient Profiles
Patients Experience Treatment
Intolerance & Suboptimal Responses
- Unmet Needs In CML
Are Your Patients Experiencing
Intolerance? Learn About Treatment.
- Treatment Option
Search results
Assetmark Inc. Boosts Stock Position in BeiGene, Ltd. (NASDAQ:BGNE)
ETF DAILY NEWS· 2 days agoAssetmark Inc. boosted its holdings in shares of BeiGene, Ltd. (NASDAQ:BGNE – Free Report) by 13.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange ...
Brokerages Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.94
ETF DAILY NEWS· 6 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports.
MEI Pharma (NASDAQ:MEIP) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock. A number of other research ...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Receives $25.60 Consensus Target Price from...
ETF DAILY NEWS· 4 days agoShares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the firm, MarketBeat ...
Aileron Therapeutics (NASDAQ:ALRN) Announces Earnings Results, Misses Estimates By $0.72 EPS
ETF DAILY NEWS· 6 days agoAileron Therapeutics (NASDAQ:ALRN – Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.14 ...
Incyte (NASDAQ:INCY) Coverage Initiated at Deutsche Bank Aktiengesellschaft
ETF DAILY NEWS· 3 days agoEquities research analysts at Deutsche Bank Aktiengesellschaft began coverage on shares of Incyte (NASDAQ:INCY – Get Free Report) in a research note issued to investors on Thursday, MarketBeat ...